These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

27 related articles for article (PubMed ID: 39184721)

  • 1. Potential Risks of Severe Infection Following the Exploratory Laparoscopy for Advanced Ovarian Cancer: A Case Report and a Literature Review.
    Fukunishi Y; Yanazume S; Nagata C; Mizuno M; Togami S; Kobayashi H
    Cureus; 2024 Jul; 16(7):e65415. PubMed ID: 39184721
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Role of diagnostic laparoscopy in deciding primary treatment in advanced-stage ovarian cancer.
    Lee YJ; Chung YS; Lee JY; Nam EJ; Kim SW; Kim YT; Kim S
    J Gynecol Oncol; 2023 Mar; 34(2):e17. PubMed ID: 36562129
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Clinical Availability of Tumour Biopsy Using Diagnostic Laparoscopy for Advanced Ovarian Cancer.
    Odajima S; Ueda K; Hosoya S; Tomita K; Kato S; Shoburu Y; Kawabata A; Iida Y; Yanaihara N; Okamoto A
    In Vivo; 2021; 35(6):3325-3331. PubMed ID: 34697165
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Concordance of a laparoscopic scoring algorithm with primary surgery findings in advanced stage ovarian cancer.
    Hansen JM; Sood AK; Coleman RL; Westin SN; Soliman PT; Ramirez PT; Fellman BM; Schmeler KM; Fleming ND
    Gynecol Oncol; 2018 Dec; 151(3):428-432. PubMed ID: 30366647
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Laparoendoscopic single-site surgery for the assessment of peritoneal carcinomatosis resectability in patients with advanced ovarian cancer.
    Rossetti D; Vitale SG; Gulino FA; Rapisarda AMC; Valenti G; Zigarelli M; Sarpietro G; Frigerio L
    Eur J Gynaecol Oncol; 2016; 37(5):671-673. PubMed ID: 29787008
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A novel algorithm for the treatment strategy for advanced epithelial ovarian cancer: consecutive imaging, frailty assessment, and diagnostic laparoscopy.
    Eoh KJ; Yoon JW; Lee JY; Nam EJ; Kim S; Kim SW; Kim YT
    BMC Cancer; 2017 Jul; 17(1):481. PubMed ID: 28701190
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Laparoscopy to Predict the Result of Primary Cytoreductive Surgery in Patients With Advanced Ovarian Cancer: A Randomized Controlled Trial.
    Rutten MJ; van Meurs HS; van de Vrie R; Gaarenstroom KN; Naaktgeboren CA; van Gorp T; Ter Brugge HG; Hofhuis W; Schreuder HW; Arts HJ; Zusterzeel PL; Pijnenborg JM; van Haaften M; Fons G; Engelen MJ; Boss EA; Vos MC; Gerestein KG; Schutter EM; Opmeer BC; Spijkerboer AM; Bossuyt PM; Mol BW; Kenter GG; Buist MR
    J Clin Oncol; 2017 Feb; 35(6):613-621. PubMed ID: 28029317
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Is complete cytoreductive surgery feasible in this patient with ovarian cancer?
    Dessapt AL; Huchon C; Ngo C; Bats AS; Bensaid C; Lecuru F
    Surg Oncol; 2016 Sep; 25(3):326-31. PubMed ID: 27566040
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparison of treatment invasiveness between upfront debulking surgery versus interval debulking surgery following neoadjuvant chemotherapy for stage III/IV ovarian, tubal, and peritoneal cancers in a phase III randomised trial: Japan Clinical Oncology Group Study JCOG0602.
    Onda T; Satoh T; Saito T; Kasamatsu T; Nakanishi T; Nakamura K; Wakabayashi M; Takehara K; Saito M; Ushijima K; Kobayashi H; Kawana K; Yokota H; Takano M; Takeshima N; Watanabe Y; Yaegashi N; Konishi I; Kamura T; Yoshikawa H;
    Eur J Cancer; 2016 Sep; 64():22-31. PubMed ID: 27323348
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A laparoscopic risk-adjusted model to predict major complications after primary debulking surgery in ovarian cancer: A single-institution assessment.
    Vizzielli G; Costantini B; Tortorella L; Pitruzzella I; Gallotta V; Fanfani F; Gueli Alletti S; Cosentino F; Nero C; Scambia G; Fagotti A
    Gynecol Oncol; 2016 Jul; 142(1):19-24. PubMed ID: 27103179
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Phase III randomised clinical trial comparing primary surgery versus neoadjuvant chemotherapy in advanced epithelial ovarian cancer with high tumour load (SCORPION trial): Final analysis of peri-operative outcome.
    Fagotti A; Ferrandina G; Vizzielli G; Fanfani F; Gallotta V; Chiantera V; Costantini B; Margariti PA; Gueli Alletti S; Cosentino F; Tortorella L; Scambia G
    Eur J Cancer; 2016 May; 59():22-33. PubMed ID: 26998845
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Definition of a dynamic laparoscopic model for the prediction of incomplete cytoreduction in advanced epithelial ovarian cancer: proof of a concept.
    Petrillo M; Vizzielli G; Fanfani F; Gallotta V; Cosentino F; Chiantera V; Legge F; Carbone V; Scambia G; Fagotti A
    Gynecol Oncol; 2015 Oct; 139(1):5-9. PubMed ID: 26196319
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Primary chemotherapy versus primary surgery for newly diagnosed advanced ovarian cancer (CHORUS): an open-label, randomised, controlled, non-inferiority trial.
    Kehoe S; Hook J; Nankivell M; Jayson GC; Kitchener H; Lopes T; Luesley D; Perren T; Bannoo S; Mascarenhas M; Dobbs S; Essapen S; Twigg J; Herod J; McCluggage G; Parmar M; Swart AM
    Lancet; 2015 Jul; 386(9990):249-57. PubMed ID: 26002111
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Introduction of staging laparoscopy in the management of advanced epithelial ovarian, tubal and peritoneal cancer: impact on prognosis in a single institution experience.
    Fagotti A; Vizzielli G; Fanfani F; Costantini B; Ferrandina G; Gallotta V; Gueli Alletti S; Tortorella L; Scambia G
    Gynecol Oncol; 2013 Nov; 131(2):341-6. PubMed ID: 23938372
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Diagnostic accuracy of hand-assisted laparoscopy in predicting resectability of peritoneal carcinomatosis from gynecological malignancies.
    Varnoux C; Huchon C; Bats AS; Bensaid C; Achouri A; Nos C; Lécuru F
    Eur J Surg Oncol; 2013 Jul; 39(7):774-9. PubMed ID: 23597496
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comparison of peritoneal carcinomatosis scoring methods in predicting resectability and prognosis in advanced ovarian cancer.
    Chéreau E; Ballester M; Selle F; Cortez A; Daraï E; Rouzier R
    Am J Obstet Gynecol; 2010 Feb; 202(2):178.e1-178.e10. PubMed ID: 20113693
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prospective validation of a laparoscopic predictive model for optimal cytoreduction in advanced ovarian carcinoma.
    Fagotti A; Ferrandina G; Fanfani F; Garganese G; Vizzielli G; Carone V; Salerno MG; Scambia G
    Am J Obstet Gynecol; 2008 Dec; 199(6):642.e1-6. PubMed ID: 18801470
    [TBL] [Abstract][Full Text] [Related]  

  • 18. External validation of a laparoscopic-based score to evaluate resectability of advanced ovarian cancers: clues for a simplified score.
    Brun JL; Rouzier R; Uzan S; Daraï E
    Gynecol Oncol; 2008 Sep; 110(3):354-9. PubMed ID: 18572226
    [TBL] [Abstract][Full Text] [Related]  

  • 19.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 2.